DexCom Inc (DXCM)
Return on total capital
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 623,000 | 730,700 | 409,400 | 275,600 | 309,700 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 2,102,600 | 2,068,600 | 2,131,800 | 2,251,500 | 1,826,500 |
| Return on total capital | 29.63% | 35.32% | 19.20% | 12.24% | 16.96% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $623,000K ÷ ($—K + $2,102,600K)
= 29.63%
DexCom Inc's return on total capital has shown fluctuations over the past five years. It stood at 16.96% as of December 31, 2020, declining to 12.24% by December 31, 2021. However, the return increased significantly to 19.20% by December 31, 2022, and continued its upward trend to reach 35.32% as of December 31, 2023. In the most recent year, as of December 31, 2024, the return on total capital was recorded at 29.63%. This indicates varying efficiency in deploying the company's capital resources to generate returns over the specified period.
Peer comparison
Dec 31, 2024